Alithia Life Sciences is proudly Australian-owned, full-service CRO partnering with pharmaceutical, biotechnology, medical device companies, and institutional research groups, offering flexible, personalised solutions to deliver high-quality clinical development programs across Australia and globally.
Why work with us
Our entire operations team is based in Australia, ensuring that our clients can maximize their R&D Tax Incentive. Each team member has on average 15 to 20+ years of combined industry and operational experience, across a broad range of trials and therapeutic areas including:
- FIH studies
- Neurology
- Devices
- Endocrinology
- Oncology
- Women’s health
- Ophthalmology
- Gastroenterology
- Cardiovascular
- Rare and Paediatric diseases
- Vaccines and more.
Alithia supports FIH and Phase I–III clinical trials, with expertise in managing investigational products across drugs, devices, Cell and Gene therapies, and combination therapies.
In addition to above, Alithia also provides clients with additional support services, including Local Directorship, Local Sponsor, and Clinical Trial Liaison services.
At Alithia, we support client through the most critical stages of clinical development with a hands‑on, thoughtful, and science‑led approach. We believe successful clinical trials are built on trust, insight, and practical execution—not volume or rigidity.
Our team works as an extension of our clients, bringing deep operational expertise, regulatory understanding, and a strong respect for the patient experience. By staying close to the data, the sites, and the people involved, we help ensure trials are delivered with precision, transparency, and purpose.
From early-stage concept through FDA approval, partners rely on us to guide every step of the clinical development journey with scientific rigor, operational excellence, and a strong commitment to advancing human health.
